Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Levocetirizine dihydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
|
Levocetirizine 2.5mg/5mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
|
Levocetirizine dihydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levocetirizine dihydrochloride 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levocetirizine dihydrochloride 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levocetirizine dihydrochloride 500 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levocetirizine dihydrochloride 500 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levocetirizine dihydrochloride 5 milligram/1 milliliter conventional release oral drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levocetirizine dihydrochloride 5 milligram/1 milliliter conventional release oral drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
2 |
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levocetirizine dihydrochloride (substance) |
Inferred relationship |
Some |
2 |